These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 22400184)

  • 21. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?
    O'Malley D; Quigley EM; Dinan TG; Cryan JF
    Brain Behav Immun; 2011 Oct; 25(7):1333-41. PubMed ID: 21536124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome.
    Suttor VP; Prott GM; Hansen RD; Kellow JE; Malcolm A
    Dis Colon Rectum; 2010 Feb; 53(2):156-60. PubMed ID: 20087090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The brain-gut axis in irritable bowel syndrome--clinical aspects.
    Mach T
    Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The pathophysiology of irritable bowel syndrome].
    Zouiten ML; Karoui S; Boubaker J; Fekih M; Mechmeche R; Filali A
    Tunis Med; 2006 May; 84(5):269-74. PubMed ID: 16915774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
    Kane JS; Ford AC
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):431-42. PubMed ID: 26753693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
    Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of Rome III criteria for diagnosing irritable bowel syndrome].
    Hattori T; Fukudo S
    Nihon Rinsho; 2006 Aug; 64(8):1425-8. PubMed ID: 16898606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome: current review on pathophysiology and diagnotic aspects.
    Abdullah M
    Acta Med Indones; 2008 Oct; 40(4):218-25. PubMed ID: 19151451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
    Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
    Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.
    Piche T; Ducrotté P; Sabate JM; Coffin B; Zerbib F; Dapoigny M; Hua M; Marine-Barjoan E; Dainese R; Hébuterne X
    Neurogastroenterol Motil; 2010 Jun; 22(6):626-e174. PubMed ID: 20403099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome.
    Smith GD
    J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
    Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L; Elia C; Navino M; Cisarò F;
    Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.
    Karling P; Danielsson A; Adolfsson R; Norrback KF
    Neurogastroenterol Motil; 2007 Nov; 19(11):896-904. PubMed ID: 17973640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.